Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.TwoStep Therapeutics secures $62.5m funding to advance TS-104
TwoStep’s approach uses a PIP that is designed to bind five tumour-associated integrins present in various solid tumours. Credit: angellodeco / Shutterstock.com.
TwoStep’s approach uses a PIP that is designed to bind five tumour-associated integrins present in various solid tumours. Credit: angellodeco / Shutterstock.com.